Loading...
OTCMNVZMY
Market cap26bUSD
Dec 20, Last price  
56.61USD
1D
1.09%
1Q
-17.55%
Jan 2017
64.04%
Name

Novozymes A/S

Chart & Performance

D1W1MN
OTCM:NVZMY chart
P/E
62.33
P/S
10.53
EPS
6.51
Div Yield, %
10.86%
Shrs. gr., 5y
-1.01%
Rev. gr., 5y
4.46%
Revenues
17.90b
+1.97%
6,024,000,0006,281,000,0006,802,000,0007,438,000,0008,146,000,0008,448,000,0009,724,000,00010,510,000,00011,234,000,00011,746,000,00012,459,000,00014,002,000,00014,142,000,00014,531,000,00014,390,000,00014,374,000,00014,012,000,00014,951,000,00017,553,000,00017,899,000,000
Net income
3.02b
-17.74%
793,000,000861,000,000911,000,0001,042,000,0001,062,000,0001,194,000,0001,614,000,0001,828,000,0002,015,000,0002,200,000,0002,526,000,0002,823,000,0003,050,000,0003,119,000,0003,226,000,0003,154,000,0002,825,000,0003,146,000,0003,676,000,0003,024,000,000
CFO
4.15b
+3.64%
1,287,000,0001,326,000,0001,534,000,0001,714,000,0001,697,000,0001,817,000,0002,324,000,0002,709,000,0002,758,000,0002,599,000,0004,525,000,0003,339,000,0003,840,000,0004,063,000,0003,679,000,0003,196,000,0004,355,000,0004,062,000,0004,006,000,0004,152,000,000
Dividend
Sep 09, 20240.04428578 USD/sh
Earnings
Feb 26, 2025

Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
URL
https://www.novozymes.com/
IPO date
May 27, 1905
Employees
6,852
Domiciled in
DK
Incorporated in
DK

Valuation

Title
DKK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
17,899,000
1.97%
17,553,000
17.40%
14,951,000
6.70%
Cost of revenue
13,518,000
13,200,000
11,132,000
Unusual Expense (Income)
NOPBT
4,381,000
4,353,000
3,819,000
NOPBT Margin
24.48%
24.80%
25.54%
Operating Taxes
870,000
870,000
779,000
Tax Rate
19.86%
19.99%
20.40%
NOPAT
3,511,000
3,483,000
3,040,000
Net income
3,024,000
-17.74%
3,676,000
16.85%
3,146,000
11.36%
Dividends
(2,856,000)
(1,524,000)
(1,465,000)
Dividend yield
2.77%
1.55%
0.97%
Proceeds from repurchase of equity
167,000
(336,000)
(1,191,000)
BB yield
-0.16%
0.34%
0.79%
Debt
Debt current
3,173,000
123,000
122,000
Long-term debt
4,929,000
699,000
842,000
Deferred revenue
129,000
98,000
Other long-term liabilities
2,218,000
4,722,000
5,093,000
Net debt
6,741,000
(534,000)
(58,000)
Cash flow
Cash from operating activities
4,152,000
4,006,000
4,062,000
CAPEX
(1,857,000)
(2,890,000)
(1,240,000)
Cash from investing activities
(2,133,000)
(2,672,000)
(2,747,000)
Cash from financing activities
(1,889,000)
(1,250,000)
(1,586,000)
FCF
4,283,000
(1,715,000)
1,939,000
Balance
Cash
1,156,000
1,121,000
1,038,000
Long term investments
205,000
235,000
(16,000)
Excess cash
466,050
478,350
274,450
Stockholders' equity
15,029,000
14,228,000
12,246,000
Invested Capital
23,835,950
18,685,650
17,118,550
ROIC
16.51%
19.46%
19.28%
ROCE
18.03%
20.91%
20.39%
EV
Common stock shares outstanding
277,875
278,734
280,228
Price
371.10
5.46%
351.90
-34.49%
537.20
53.99%
Market cap
103,119,402
5.13%
98,086,466
-34.84%
150,538,538
53.01%
EV
110,572,402
97,943,466
150,899,538
EBITDA
5,770,000
5,810,000
5,235,000
EV/EBITDA
19.16
16.86
28.83
Interest
173,000
102,000
102,000
Interest/NOPBT
3.95%
2.34%
2.67%